| GO:0061650 | ubiquitin-like protein conjugating enzyme activity | 11.43% (8/70) | 6.17 | 0.0 | 0.0 |
| GO:0098876 | vesicle-mediated transport to the plasma membrane | 14.29% (10/70) | 5.05 | 0.0 | 0.0 |
| GO:0032991 | protein-containing complex | 47.14% (33/70) | 1.93 | 0.0 | 0.0 |
| GO:0061631 | ubiquitin conjugating enzyme activity | 10.0% (7/70) | 6.29 | 0.0 | 0.0 |
| GO:0031001 | response to brefeldin A | 7.14% (5/70) | 8.13 | 0.0 | 0.0 |
| GO:0070936 | protein K48-linked ubiquitination | 11.43% (8/70) | 5.44 | 0.0 | 0.0 |
| GO:0000151 | ubiquitin ligase complex | 17.14% (12/70) | 3.88 | 0.0 | 0.0 |
| GO:0016004 | phospholipase activator activity | 7.14% (5/70) | 7.54 | 0.0 | 0.0 |
| GO:0060229 | lipase activator activity | 7.14% (5/70) | 7.54 | 0.0 | 0.0 |
| GO:0006513 | protein monoubiquitination | 11.43% (8/70) | 5.1 | 0.0 | 0.0 |
| GO:0051668 | localization within membrane | 17.14% (12/70) | 3.74 | 0.0 | 0.0 |
| GO:0070534 | protein K63-linked ubiquitination | 10.0% (7/70) | 5.57 | 0.0 | 0.0 |
| GO:0030674 | protein-macromolecule adaptor activity | 12.86% (9/70) | 4.42 | 0.0 | 0.0 |
| GO:0044265 | cellular macromolecule catabolic process | 21.43% (15/70) | 2.95 | 0.0 | 0.0 |
| GO:0019904 | protein domain specific binding | 17.14% (12/70) | 3.43 | 0.0 | 0.0 |
| GO:0006471 | protein ADP-ribosylation | 7.14% (5/70) | 6.59 | 0.0 | 0.0 |
| GO:0060090 | molecular adaptor activity | 12.86% (9/70) | 4.17 | 0.0 | 0.0 |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 15.71% (11/70) | 3.59 | 0.0 | 0.0 |
| GO:0140535 | intracellular protein-containing complex | 20.0% (14/70) | 2.95 | 0.0 | 0.0 |
| GO:0000209 | protein polyubiquitination | 12.86% (9/70) | 4.07 | 0.0 | 0.0 |
| GO:0016192 | vesicle-mediated transport | 20.0% (14/70) | 2.93 | 0.0 | 0.0 |
| GO:0010498 | proteasomal protein catabolic process | 15.71% (11/70) | 3.47 | 0.0 | 0.0 |
| GO:0035519 | protein K29-linked ubiquitination | 5.71% (4/70) | 7.42 | 0.0 | 1e-06 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 17.14% (12/70) | 3.18 | 0.0 | 1e-06 |
| GO:0019941 | modification-dependent protein catabolic process | 17.14% (12/70) | 3.18 | 0.0 | 1e-06 |
| GO:0070628 | proteasome binding | 7.14% (5/70) | 6.16 | 0.0 | 1e-06 |
| GO:0099024 | plasma membrane invagination | 7.14% (5/70) | 6.13 | 0.0 | 1e-06 |
| GO:0043632 | modification-dependent macromolecule catabolic process | 17.14% (12/70) | 3.13 | 0.0 | 1e-06 |
| GO:0005515 | protein binding | 71.43% (50/70) | 0.92 | 0.0 | 1e-06 |
| GO:0015031 | protein transport | 20.0% (14/70) | 2.78 | 0.0 | 1e-06 |
| GO:0046907 | intracellular transport | 21.43% (15/70) | 2.63 | 0.0 | 1e-06 |
| GO:0030163 | protein catabolic process | 15.71% (11/70) | 3.28 | 0.0 | 1e-06 |
| GO:0072671 | mitochondria-associated ubiquitin-dependent protein catabolic process | 5.71% (4/70) | 7.04 | 0.0 | 1e-06 |
| GO:0045184 | establishment of protein localization | 20.0% (14/70) | 2.69 | 0.0 | 1e-06 |
| GO:0070979 | protein K11-linked ubiquitination | 7.14% (5/70) | 5.8 | 0.0 | 2e-06 |
| GO:0003924 | GTPase activity | 11.43% (8/70) | 4.03 | 0.0 | 2e-06 |
| GO:0009057 | macromolecule catabolic process | 21.43% (15/70) | 2.51 | 0.0 | 2e-06 |
| GO:0044314 | protein K27-linked ubiquitination | 5.71% (4/70) | 6.8 | 0.0 | 2e-06 |
| GO:1990116 | ribosome-associated ubiquitin-dependent protein catabolic process | 5.71% (4/70) | 6.8 | 0.0 | 2e-06 |
| GO:0090174 | organelle membrane fusion | 8.57% (6/70) | 4.97 | 0.0 | 2e-06 |
| GO:0010324 | membrane invagination | 7.14% (5/70) | 5.69 | 0.0 | 2e-06 |
| GO:0051603 | proteolysis involved in protein catabolic process | 17.14% (12/70) | 2.95 | 0.0 | 2e-06 |
| GO:0072344 | rescue of stalled ribosome | 5.71% (4/70) | 6.73 | 0.0 | 2e-06 |
| GO:0071629 | cytoplasm protein quality control by the ubiquitin-proteasome system | 7.14% (5/70) | 5.61 | 0.0 | 3e-06 |
| GO:0140455 | cytoplasm protein quality control | 7.14% (5/70) | 5.61 | 0.0 | 3e-06 |
| GO:1903335 | regulation of vacuolar transport | 5.71% (4/70) | 6.67 | 0.0 | 3e-06 |
| GO:0039020 | pronephric nephron tubule development | 5.71% (4/70) | 6.67 | 0.0 | 3e-06 |
| GO:0004842 | ubiquitin-protein transferase activity | 15.71% (11/70) | 3.08 | 0.0 | 3e-06 |
| GO:0005654 | nucleoplasm | 22.86% (16/70) | 2.32 | 0.0 | 3e-06 |
| GO:0005525 | GTP binding | 11.43% (8/70) | 3.85 | 0.0 | 3e-06 |
| GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 5.71% (4/70) | 6.54 | 0.0 | 4e-06 |
| GO:0019787 | ubiquitin-like protein transferase activity | 15.71% (11/70) | 3.02 | 0.0 | 4e-06 |
| GO:0016050 | vesicle organization | 11.43% (8/70) | 3.81 | 0.0 | 4e-06 |
| GO:0072009 | nephron epithelium development | 5.71% (4/70) | 6.48 | 0.0 | 4e-06 |
| GO:0072080 | nephron tubule development | 5.71% (4/70) | 6.48 | 0.0 | 4e-06 |
| GO:0042731 | PH domain binding | 4.29% (3/70) | 8.13 | 0.0 | 4e-06 |
| GO:0051649 | establishment of localization in cell | 21.43% (15/70) | 2.4 | 0.0 | 4e-06 |
| GO:0005829 | cytosol | 40.0% (28/70) | 1.49 | 0.0 | 4e-06 |
| GO:0061025 | membrane fusion | 8.57% (6/70) | 4.7 | 0.0 | 4e-06 |
| GO:0085020 | protein K6-linked ubiquitination | 5.71% (4/70) | 6.42 | 0.0 | 4e-06 |
| GO:0072073 | kidney epithelium development | 5.71% (4/70) | 6.37 | 0.0 | 5e-06 |
| GO:0032561 | guanyl ribonucleotide binding | 11.43% (8/70) | 3.72 | 0.0 | 5e-06 |
| GO:0044248 | cellular catabolic process | 27.14% (19/70) | 1.98 | 0.0 | 5e-06 |
| GO:0031252 | cell leading edge | 7.14% (5/70) | 5.3 | 0.0 | 5e-06 |
| GO:0005769 | early endosome | 10.0% (7/70) | 4.1 | 0.0 | 5e-06 |
| GO:0016925 | protein sumoylation | 5.71% (4/70) | 6.32 | 0.0 | 5e-06 |
| GO:0019001 | guanyl nucleotide binding | 11.43% (8/70) | 3.71 | 0.0 | 5e-06 |
| GO:0008104 | protein localization | 21.43% (15/70) | 2.33 | 0.0 | 6e-06 |
| GO:0006886 | intracellular protein transport | 15.71% (11/70) | 2.89 | 0.0 | 7e-06 |
| GO:0032555 | purine ribonucleotide binding | 25.71% (18/70) | 2.02 | 0.0 | 7e-06 |
| GO:0017076 | purine nucleotide binding | 25.71% (18/70) | 2.01 | 0.0 | 7e-06 |
| GO:0061951 | establishment of protein localization to plasma membrane | 7.14% (5/70) | 5.16 | 0.0 | 8e-06 |
| GO:0046677 | response to antibiotic | 7.14% (5/70) | 5.13 | 0.0 | 9e-06 |
| GO:0032553 | ribonucleotide binding | 25.71% (18/70) | 1.98 | 0.0 | 9e-06 |
| GO:0034976 | response to endoplasmic reticulum stress | 10.0% (7/70) | 3.92 | 0.0 | 1e-05 |
| GO:0043001 | Golgi to plasma membrane protein transport | 5.71% (4/70) | 6.04 | 0.0 | 1e-05 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 24.29% (17/70) | 2.05 | 0.0 | 1.1e-05 |
| GO:1990234 | transferase complex | 17.14% (12/70) | 2.63 | 0.0 | 1.1e-05 |
| GO:0051641 | cellular localization | 24.29% (17/70) | 2.04 | 0.0 | 1.1e-05 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 11.43% (8/70) | 3.5 | 1e-06 | 1.3e-05 |
| GO:0061326 | renal tubule development | 5.71% (4/70) | 5.92 | 1e-06 | 1.3e-05 |
| GO:0033036 | macromolecule localization | 22.86% (16/70) | 2.11 | 1e-06 | 1.3e-05 |
| GO:0006892 | post-Golgi vesicle-mediated transport | 8.57% (6/70) | 4.28 | 1e-06 | 1.5e-05 |
| GO:0051130 | positive regulation of cellular component organization | 14.29% (10/70) | 2.92 | 1e-06 | 1.7e-05 |
| GO:0070727 | cellular macromolecule localization | 21.43% (15/70) | 2.17 | 1e-06 | 1.8e-05 |
| GO:0009734 | auxin-activated signaling pathway | 11.43% (8/70) | 3.42 | 1e-06 | 1.8e-05 |
| GO:0005488 | binding | 78.57% (55/70) | 0.65 | 1e-06 | 1.8e-05 |
| GO:0097367 | carbohydrate derivative binding | 25.71% (18/70) | 1.9 | 1e-06 | 1.8e-05 |
| GO:1990386 | mitotic cleavage furrow ingression | 4.29% (3/70) | 7.25 | 1e-06 | 1.9e-05 |
| GO:0006508 | proteolysis | 18.57% (13/70) | 2.39 | 1e-06 | 2e-05 |
| GO:0045177 | apical part of cell | 7.14% (5/70) | 4.8 | 1e-06 | 2.1e-05 |
| GO:0006906 | vesicle fusion | 7.14% (5/70) | 4.8 | 1e-06 | 2.1e-05 |
| GO:0048280 | vesicle fusion with Golgi apparatus | 4.29% (3/70) | 7.13 | 1e-06 | 2.4e-05 |
| GO:0051223 | regulation of protein transport | 10.0% (7/70) | 3.68 | 1e-06 | 2.5e-05 |
| GO:0071705 | nitrogen compound transport | 21.43% (15/70) | 2.11 | 1e-06 | 2.7e-05 |
| GO:0005484 | SNAP receptor activity | 5.71% (4/70) | 5.57 | 2e-06 | 3.1e-05 |
| GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.71% (4/70) | 5.54 | 2e-06 | 3.3e-05 |
| GO:1901565 | organonitrogen compound catabolic process | 17.14% (12/70) | 2.45 | 2e-06 | 3.3e-05 |
| GO:0061024 | membrane organization | 12.86% (9/70) | 2.99 | 2e-06 | 3.6e-05 |
| GO:0048284 | organelle fusion | 8.57% (6/70) | 3.99 | 2e-06 | 4.2e-05 |
| GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 7.14% (5/70) | 4.56 | 2e-06 | 4.4e-05 |
| GO:1901575 | organic substance catabolic process | 25.71% (18/70) | 1.79 | 3e-06 | 4.6e-05 |
| GO:0009960 | endosperm development | 7.14% (5/70) | 4.53 | 3e-06 | 4.8e-05 |
| GO:0070201 | regulation of establishment of protein localization | 10.0% (7/70) | 3.5 | 3e-06 | 5.3e-05 |
| GO:0090354 | regulation of auxin metabolic process | 7.14% (5/70) | 4.49 | 3e-06 | 5.3e-05 |
| GO:0016462 | pyrophosphatase activity | 11.43% (8/70) | 3.15 | 3e-06 | 5.9e-05 |
| GO:0033962 | P-body assembly | 4.29% (3/70) | 6.62 | 4e-06 | 6.3e-05 |
| GO:0120115 | Lsm2-8 complex | 4.29% (3/70) | 6.62 | 4e-06 | 6.3e-05 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 11.43% (8/70) | 3.13 | 4e-06 | 6.3e-05 |
| GO:0032446 | protein modification by small protein conjugation | 15.71% (11/70) | 2.49 | 4e-06 | 6.3e-05 |
| GO:0009056 | catabolic process | 27.14% (19/70) | 1.67 | 4e-06 | 6.7e-05 |
| GO:0043130 | ubiquitin binding | 7.14% (5/70) | 4.4 | 4e-06 | 6.8e-05 |
| GO:0036090 | cleavage furrow ingression | 4.29% (3/70) | 6.54 | 4e-06 | 7.2e-05 |
| GO:0031201 | SNARE complex | 5.71% (4/70) | 5.19 | 5e-06 | 7.4e-05 |
| GO:0048193 | Golgi vesicle transport | 10.0% (7/70) | 3.4 | 5e-06 | 7.4e-05 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 11.43% (8/70) | 3.08 | 5e-06 | 7.7e-05 |
| GO:0006996 | organelle organization | 25.71% (18/70) | 1.72 | 5e-06 | 7.8e-05 |
| GO:0090150 | establishment of protein localization to membrane | 8.57% (6/70) | 3.79 | 5e-06 | 7.8e-05 |
| GO:0007269 | neurotransmitter secretion | 4.29% (3/70) | 6.46 | 5e-06 | 8e-05 |
| GO:0005688 | U6 snRNP | 4.29% (3/70) | 6.46 | 5e-06 | 8e-05 |
| GO:0043005 | neuron projection | 11.43% (8/70) | 3.05 | 6e-06 | 8.6e-05 |
| GO:1902494 | catalytic complex | 20.0% (14/70) | 2.04 | 6e-06 | 8.9e-05 |
| GO:0000910 | cytokinesis | 8.57% (6/70) | 3.67 | 8e-06 | 0.000119 |
| GO:0032182 | ubiquitin-like protein binding | 7.14% (5/70) | 4.21 | 8e-06 | 0.000119 |
| GO:0051128 | regulation of cellular component organization | 21.43% (15/70) | 1.88 | 9e-06 | 0.000138 |
| GO:0019003 | GDP binding | 5.71% (4/70) | 4.94 | 9e-06 | 0.000138 |
| GO:0032386 | regulation of intracellular transport | 8.57% (6/70) | 3.62 | 1e-05 | 0.000141 |
| GO:0006893 | Golgi to plasma membrane transport | 5.71% (4/70) | 4.9 | 1e-05 | 0.00015 |
| GO:0030135 | coated vesicle | 7.14% (5/70) | 4.13 | 1.1e-05 | 0.000151 |
| GO:0017070 | U6 snRNA binding | 4.29% (3/70) | 6.07 | 1.2e-05 | 0.000175 |
| GO:0043170 | macromolecule metabolic process | 45.71% (32/70) | 1.03 | 1.3e-05 | 0.000181 |
| GO:0031625 | ubiquitin protein ligase binding | 10.0% (7/70) | 3.17 | 1.3e-05 | 0.000183 |
| GO:0071702 | organic substance transport | 21.43% (15/70) | 1.84 | 1.3e-05 | 0.000184 |
| GO:0070647 | protein modification by small protein conjugation or removal | 15.71% (11/70) | 2.28 | 1.4e-05 | 0.000197 |
| GO:0043168 | anion binding | 25.71% (18/70) | 1.6 | 1.5e-05 | 0.000204 |
| GO:0006414 | translational elongation | 5.71% (4/70) | 4.73 | 1.6e-05 | 0.00022 |
| GO:0008047 | enzyme activator activity | 8.57% (6/70) | 3.49 | 1.6e-05 | 0.000221 |
| GO:0072659 | protein localization to plasma membrane | 7.14% (5/70) | 3.97 | 1.8e-05 | 0.000234 |
| GO:0016567 | protein ubiquitination | 14.29% (10/70) | 2.41 | 1.8e-05 | 0.000235 |
| GO:0044389 | ubiquitin-like protein ligase binding | 10.0% (7/70) | 3.1 | 1.8e-05 | 0.000236 |
| GO:0031902 | late endosome membrane | 5.71% (4/70) | 4.68 | 1.9e-05 | 0.000246 |
| GO:0032350 | regulation of hormone metabolic process | 7.14% (5/70) | 3.94 | 2e-05 | 0.000255 |
| GO:0005575 | cellular_component | 84.29% (59/70) | 0.47 | 2.1e-05 | 0.000266 |
| GO:0048471 | perinuclear region of cytoplasm | 10.0% (7/70) | 3.04 | 2.4e-05 | 0.000301 |
| GO:0044260 | cellular macromolecule metabolic process | 25.71% (18/70) | 1.55 | 2.4e-05 | 0.000309 |
| GO:0071011 | precatalytic spliceosome | 5.71% (4/70) | 4.57 | 2.5e-05 | 0.000322 |
| GO:0019538 | protein metabolic process | 32.86% (23/70) | 1.29 | 2.6e-05 | 0.000324 |
| GO:0022607 | cellular component assembly | 21.43% (15/70) | 1.76 | 2.7e-05 | 0.000333 |
| GO:0006807 | nitrogen compound metabolic process | 51.43% (36/70) | 0.88 | 2.8e-05 | 0.000342 |
| GO:0099643 | signal release from synapse | 4.29% (3/70) | 5.67 | 2.9e-05 | 0.000353 |
| GO:0065003 | protein-containing complex assembly | 15.71% (11/70) | 2.17 | 2.9e-05 | 0.000354 |
| GO:0099003 | vesicle-mediated transport in synapse | 5.71% (4/70) | 4.51 | 3e-05 | 0.000362 |
| GO:0000149 | SNARE binding | 5.71% (4/70) | 4.51 | 3e-05 | 0.000362 |
| GO:0097525 | spliceosomal snRNP complex | 5.71% (4/70) | 4.47 | 3.4e-05 | 0.000405 |
| GO:0000387 | spliceosomal snRNP assembly | 4.29% (3/70) | 5.5 | 4.1e-05 | 0.000487 |
| GO:0048488 | synaptic vesicle endocytosis | 4.29% (3/70) | 5.46 | 4.4e-05 | 0.000522 |
| GO:0140238 | presynaptic endocytosis | 4.29% (3/70) | 5.46 | 4.4e-05 | 0.000522 |
| GO:0002278 | eosinophil activation involved in immune response | 2.86% (2/70) | 7.54 | 4.7e-05 | 0.000535 |
| GO:0002283 | neutrophil activation involved in immune response | 2.86% (2/70) | 7.54 | 4.7e-05 | 0.000535 |
| GO:0034197 | triglyceride transport | 2.86% (2/70) | 7.54 | 4.7e-05 | 0.000535 |
| GO:0043307 | eosinophil activation | 2.86% (2/70) | 7.54 | 4.7e-05 | 0.000535 |
| GO:0043308 | eosinophil degranulation | 2.86% (2/70) | 7.54 | 4.7e-05 | 0.000535 |
| GO:0043312 | neutrophil degranulation | 2.86% (2/70) | 7.54 | 4.7e-05 | 0.000535 |
| GO:1903047 | mitotic cell cycle process | 11.43% (8/70) | 2.62 | 4.8e-05 | 0.000541 |
| GO:0030532 | small nuclear ribonucleoprotein complex | 5.71% (4/70) | 4.33 | 4.9e-05 | 0.000547 |
| GO:0006810 | transport | 28.57% (20/70) | 1.36 | 5e-05 | 0.000556 |
| GO:0036211 | protein modification process | 27.14% (19/70) | 1.42 | 5.1e-05 | 0.000561 |
| GO:0120114 | Sm-like protein family complex | 5.71% (4/70) | 4.29 | 5.4e-05 | 0.000592 |
| GO:1990778 | protein localization to cell periphery | 7.14% (5/70) | 3.63 | 5.4e-05 | 0.000593 |
| GO:0031410 | cytoplasmic vesicle | 18.57% (13/70) | 1.83 | 5.9e-05 | 0.000646 |
| GO:0032011 | ARF protein signal transduction | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:0034196 | acylglycerol transport | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:0042119 | neutrophil activation | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:1900483 | regulation of protein targeting to vacuolar membrane | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:0055108 | Golgi to transport vesicle transport | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:1902824 | positive regulation of late endosome to lysosome transport | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:1903337 | positive regulation of vacuolar transport | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:1990583 | phospholipase D activator activity | 2.86% (2/70) | 7.32 | 6.6e-05 | 0.000681 |
| GO:0010008 | endosome membrane | 8.57% (6/70) | 3.13 | 6.7e-05 | 0.000684 |
| GO:0032940 | secretion by cell | 7.14% (5/70) | 3.56 | 6.8e-05 | 0.000686 |
| GO:0022402 | cell cycle process | 15.71% (11/70) | 2.04 | 6.8e-05 | 0.000689 |
| GO:0060429 | epithelium development | 5.71% (4/70) | 4.18 | 7.3e-05 | 0.000735 |
| GO:0051179 | localization | 31.43% (22/70) | 1.23 | 7.4e-05 | 0.00074 |
| GO:0030433 | ubiquitin-dependent ERAD pathway | 5.71% (4/70) | 4.17 | 7.5e-05 | 0.000751 |
| GO:0051865 | protein autoubiquitination | 7.14% (5/70) | 3.52 | 7.9e-05 | 0.000781 |
| GO:0097708 | intracellular vesicle | 18.57% (13/70) | 1.79 | 7.9e-05 | 0.000785 |
| GO:0006836 | neurotransmitter transport | 4.29% (3/70) | 5.16 | 8.4e-05 | 0.000819 |
| GO:1902410 | mitotic cytokinetic process | 4.29% (3/70) | 5.16 | 8.4e-05 | 0.000819 |
| GO:0006878 | cellular copper ion homeostasis | 4.29% (3/70) | 5.16 | 8.4e-05 | 0.000819 |
| GO:0032880 | regulation of protein localization | 10.0% (7/70) | 2.74 | 8.8e-05 | 0.000832 |
| GO:0035493 | SNARE complex assembly | 2.86% (2/70) | 7.13 | 8.8e-05 | 0.000836 |
| GO:0043299 | leukocyte degranulation | 2.86% (2/70) | 7.13 | 8.8e-05 | 0.000836 |
| GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 2.86% (2/70) | 7.13 | 8.8e-05 | 0.000836 |
| GO:0060292 | long-term synaptic depression | 2.86% (2/70) | 7.13 | 8.8e-05 | 0.000836 |
| GO:0003674 | molecular_function | 81.43% (57/70) | 0.45 | 8.9e-05 | 0.000837 |
| GO:0072657 | protein localization to membrane | 8.57% (6/70) | 3.05 | 8.9e-05 | 0.000842 |
| GO:0009504 | cell plate | 5.71% (4/70) | 4.1 | 9e-05 | 0.000842 |
| GO:0051234 | establishment of localization | 28.57% (20/70) | 1.3 | 9.3e-05 | 0.000865 |
| GO:0043228 | non-membrane-bounded organelle | 24.29% (17/70) | 1.46 | 9.6e-05 | 0.000882 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 24.29% (17/70) | 1.46 | 9.6e-05 | 0.000882 |
| GO:0007033 | vacuole organization | 7.14% (5/70) | 3.45 | 9.7e-05 | 0.000885 |
| GO:0044877 | protein-containing complex binding | 12.86% (9/70) | 2.28 | 9.6e-05 | 0.000885 |
| GO:0019899 | enzyme binding | 18.57% (13/70) | 1.76 | 9.8e-05 | 0.00089 |
| GO:0043933 | protein-containing complex organization | 15.71% (11/70) | 1.97 | 0.0001 | 0.000903 |
| GO:0000153 | cytoplasmic ubiquitin ligase complex | 4.29% (3/70) | 5.04 | 0.000108 | 0.000965 |
| GO:0098686 | hippocampal mossy fiber to CA3 synapse | 2.86% (2/70) | 6.96 | 0.000113 | 0.001002 |
| GO:0012507 | ER to Golgi transport vesicle membrane | 2.86% (2/70) | 6.96 | 0.000113 | 0.001002 |
| GO:0046540 | U4/U6 x U5 tri-snRNP complex | 4.29% (3/70) | 4.98 | 0.000121 | 0.001067 |
| GO:0042995 | cell projection | 14.29% (10/70) | 2.07 | 0.000128 | 0.001119 |
| GO:0097526 | spliceosomal tri-snRNP complex | 4.29% (3/70) | 4.96 | 0.000128 | 0.001123 |
| GO:0099503 | secretory vesicle | 7.14% (5/70) | 3.36 | 0.000129 | 0.001126 |
| GO:0019005 | SCF ubiquitin ligase complex | 5.71% (4/70) | 3.96 | 0.000134 | 0.001162 |
| GO:0098858 | actin-based cell projection | 4.29% (3/70) | 4.93 | 0.000135 | 0.001164 |
| GO:0070862 | negative regulation of protein exit from endoplasmic reticulum | 2.86% (2/70) | 6.8 | 0.000141 | 0.001183 |
| GO:1904153 | negative regulation of retrograde protein transport, ER to cytosol | 2.86% (2/70) | 6.8 | 0.000141 | 0.001183 |
| GO:0042275 | error-free postreplication DNA repair | 2.86% (2/70) | 6.8 | 0.000141 | 0.001183 |
| GO:0098974 | postsynaptic actin cytoskeleton organization | 2.86% (2/70) | 6.8 | 0.000141 | 0.001183 |
| GO:0099188 | postsynaptic cytoskeleton organization | 2.86% (2/70) | 6.8 | 0.000141 | 0.001183 |
| GO:1902822 | regulation of late endosome to lysosome transport | 2.86% (2/70) | 6.8 | 0.000141 | 0.001183 |
| GO:0055070 | copper ion homeostasis | 4.29% (3/70) | 4.9 | 0.000142 | 0.00119 |
| GO:0060284 | regulation of cell development | 7.14% (5/70) | 3.33 | 0.000146 | 0.0012 |
| GO:0043412 | macromolecule modification | 28.57% (20/70) | 1.25 | 0.000145 | 0.001204 |
| GO:0036503 | ERAD pathway | 5.71% (4/70) | 3.93 | 0.000145 | 0.001207 |
| GO:0000166 | nucleotide binding | 25.71% (18/70) | 1.34 | 0.000164 | 0.001341 |
| GO:1901265 | nucleoside phosphate binding | 25.71% (18/70) | 1.34 | 0.000164 | 0.001341 |
| GO:0002275 | myeloid cell activation involved in immune response | 2.86% (2/70) | 6.67 | 0.000172 | 0.001393 |
| GO:0036230 | granulocyte activation | 2.86% (2/70) | 6.67 | 0.000172 | 0.001393 |
| GO:0005684 | U2-type spliceosomal complex | 5.71% (4/70) | 3.85 | 0.000178 | 0.001434 |
| GO:0031301 | integral component of organelle membrane | 7.14% (5/70) | 3.23 | 0.000198 | 0.001589 |
| GO:0031982 | vesicle | 18.57% (13/70) | 1.66 | 0.000202 | 0.001613 |
| GO:1904152 | regulation of retrograde protein transport, ER to cytosol | 2.86% (2/70) | 6.54 | 0.000206 | 0.00162 |
| GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.86% (2/70) | 6.54 | 0.000206 | 0.00162 |
| GO:0034377 | plasma lipoprotein particle assembly | 2.86% (2/70) | 6.54 | 0.000206 | 0.00162 |
| GO:0034379 | very-low-density lipoprotein particle assembly | 2.86% (2/70) | 6.54 | 0.000206 | 0.00162 |
| GO:0035295 | tube development | 5.71% (4/70) | 3.79 | 0.000211 | 0.001648 |
| GO:0000932 | P-body | 5.71% (4/70) | 3.78 | 0.000216 | 0.00168 |
| GO:0046903 | secretion | 7.14% (5/70) | 3.19 | 0.000227 | 0.001762 |
| GO:0017069 | snRNA binding | 4.29% (3/70) | 4.67 | 0.000232 | 0.001793 |
| GO:0060341 | regulation of cellular localization | 10.0% (7/70) | 2.5 | 0.000239 | 0.001839 |
| GO:0017158 | regulation of calcium ion-dependent exocytosis | 2.86% (2/70) | 6.42 | 0.000243 | 0.001857 |
| GO:0023061 | signal release | 4.29% (3/70) | 4.64 | 0.000243 | 0.001859 |
| GO:0120036 | plasma membrane bounded cell projection organization | 7.14% (5/70) | 3.16 | 0.000248 | 0.001887 |
| GO:0061640 | cytoskeleton-dependent cytokinesis | 5.71% (4/70) | 3.72 | 0.000253 | 0.0019 |
| GO:0033157 | regulation of intracellular protein transport | 5.71% (4/70) | 3.72 | 0.000253 | 0.0019 |
| GO:0005681 | spliceosomal complex | 7.14% (5/70) | 3.16 | 0.000252 | 0.001907 |
| GO:0002786 | regulation of antibacterial peptide production | 2.86% (2/70) | 6.32 | 0.000284 | 0.002112 |
| GO:0051285 | cell cortex of cell tip | 2.86% (2/70) | 6.32 | 0.000284 | 0.002112 |
| GO:0031344 | regulation of cell projection organization | 7.14% (5/70) | 3.1 | 0.0003 | 0.002222 |
| GO:0010720 | positive regulation of cell development | 5.71% (4/70) | 3.62 | 0.000328 | 0.002413 |
| GO:0030137 | COPI-coated vesicle | 2.86% (2/70) | 6.22 | 0.000327 | 0.002414 |
| GO:0110165 | cellular anatomical entity | 80.0% (56/70) | 0.41 | 0.000331 | 0.002425 |
| GO:0120025 | plasma membrane bounded cell projection | 12.86% (9/70) | 2.03 | 0.000335 | 0.002444 |
| GO:0051049 | regulation of transport | 14.29% (10/70) | 1.88 | 0.000356 | 0.002591 |
| GO:0009558 | embryo sac cellularization | 2.86% (2/70) | 6.13 | 0.000373 | 0.00264 |
| GO:0006911 | phagocytosis, engulfment | 2.86% (2/70) | 6.13 | 0.000373 | 0.00264 |
| GO:0030285 | integral component of synaptic vesicle membrane | 2.86% (2/70) | 6.13 | 0.000373 | 0.00264 |
| GO:0033263 | CORVET complex | 2.86% (2/70) | 6.13 | 0.000373 | 0.00264 |
| GO:0065005 | protein-lipid complex assembly | 2.86% (2/70) | 6.13 | 0.000373 | 0.00264 |
| GO:0035556 | intracellular signal transduction | 12.86% (9/70) | 2.02 | 0.000366 | 0.002649 |
| GO:0045202 | synapse | 8.57% (6/70) | 2.67 | 0.000373 | 0.002687 |
| GO:0070925 | organelle assembly | 8.57% (6/70) | 2.65 | 0.000399 | 0.002815 |
| GO:0031346 | positive regulation of cell projection organization | 5.71% (4/70) | 3.53 | 0.00041 | 0.002874 |
| GO:0000331 | contractile vacuole | 2.86% (2/70) | 6.04 | 0.000423 | 0.002921 |
| GO:0030175 | filopodium | 2.86% (2/70) | 6.04 | 0.000423 | 0.002921 |
| GO:0098984 | neuron to neuron synapse | 2.86% (2/70) | 6.04 | 0.000423 | 0.002921 |
| GO:1903307 | positive regulation of regulated secretory pathway | 2.86% (2/70) | 6.04 | 0.000423 | 0.002921 |
| GO:0007264 | small GTPase mediated signal transduction | 4.29% (3/70) | 4.37 | 0.000425 | 0.002924 |
| GO:0032506 | cytokinetic process | 4.29% (3/70) | 4.35 | 0.00044 | 0.002998 |
| GO:0071005 | U2-type precatalytic spliceosome | 4.29% (3/70) | 4.35 | 0.00044 | 0.002998 |
| GO:0031300 | intrinsic component of organelle membrane | 7.14% (5/70) | 2.98 | 0.000437 | 0.002998 |
| GO:0001745 | compound eye morphogenesis | 2.86% (2/70) | 5.96 | 0.000475 | 0.003199 |
| GO:0032391 | photoreceptor connecting cilium | 2.86% (2/70) | 5.96 | 0.000475 | 0.003199 |
| GO:0035869 | ciliary transition zone | 2.86% (2/70) | 5.96 | 0.000475 | 0.003199 |
| GO:0098852 | lytic vacuole membrane | 5.71% (4/70) | 3.47 | 0.000486 | 0.003264 |
| GO:0032456 | endocytic recycling | 4.29% (3/70) | 4.3 | 0.000489 | 0.003271 |
| GO:0001505 | regulation of neurotransmitter levels | 4.29% (3/70) | 4.28 | 0.000506 | 0.003372 |
| GO:1904799 | regulation of neuron remodeling | 2.86% (2/70) | 5.88 | 0.00053 | 0.00347 |
| GO:1904801 | positive regulation of neuron remodeling | 2.86% (2/70) | 5.88 | 0.00053 | 0.00347 |
| GO:0071827 | plasma lipoprotein particle organization | 2.86% (2/70) | 5.88 | 0.00053 | 0.00347 |
| GO:0044238 | primary metabolic process | 51.43% (36/70) | 0.69 | 0.000525 | 0.003476 |
| GO:0018995 | host cellular component | 4.29% (3/70) | 4.27 | 0.000523 | 0.003476 |
| GO:0036094 | small molecule binding | 25.71% (18/70) | 1.2 | 0.000557 | 0.003636 |
| GO:0005798 | Golgi-associated vesicle | 4.29% (3/70) | 4.23 | 0.000559 | 0.003636 |
| GO:0030897 | HOPS complex | 2.86% (2/70) | 5.8 | 0.000588 | 0.003784 |
| GO:0031371 | ubiquitin conjugating enzyme complex | 2.86% (2/70) | 5.8 | 0.000588 | 0.003784 |
| GO:0097061 | dendritic spine organization | 2.86% (2/70) | 5.8 | 0.000588 | 0.003784 |
| GO:0019901 | protein kinase binding | 8.57% (6/70) | 2.53 | 0.000616 | 0.003948 |
| GO:0030100 | regulation of endocytosis | 5.71% (4/70) | 3.36 | 0.000636 | 0.004062 |
| GO:0099173 | postsynapse organization | 2.86% (2/70) | 5.73 | 0.000649 | 0.004106 |
| GO:1902307 | positive regulation of sodium ion transmembrane transport | 2.86% (2/70) | 5.73 | 0.000649 | 0.004106 |
| GO:0051960 | regulation of nervous system development | 5.71% (4/70) | 3.36 | 0.000647 | 0.004118 |
| GO:0048167 | regulation of synaptic plasticity | 4.29% (3/70) | 4.16 | 0.000656 | 0.004133 |
| GO:0007165 | signal transduction | 24.29% (17/70) | 1.22 | 0.000691 | 0.004338 |
| GO:0048259 | regulation of receptor-mediated endocytosis | 4.29% (3/70) | 4.13 | 0.000697 | 0.00435 |
| GO:0050708 | regulation of protein secretion | 4.29% (3/70) | 4.13 | 0.000697 | 0.00435 |
| GO:0002784 | regulation of antimicrobial peptide production | 2.86% (2/70) | 5.67 | 0.000714 | 0.00442 |
| GO:0061484 | hematopoietic stem cell homeostasis | 2.86% (2/70) | 5.67 | 0.000714 | 0.00442 |
| GO:0019900 | kinase binding | 10.0% (7/70) | 2.23 | 0.000718 | 0.004433 |
| GO:0008150 | biological_process | 80.0% (56/70) | 0.38 | 0.000737 | 0.004536 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 7.14% (5/70) | 2.81 | 0.000759 | 0.004656 |
| GO:0002759 | regulation of antimicrobial humoral response | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0090313 | regulation of protein targeting to membrane | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0051125 | regulation of actin nucleation | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0070142 | synaptic vesicle budding | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0071825 | protein-lipid complex subunit organization | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0097212 | lysosomal membrane organization | 2.86% (2/70) | 5.6 | 0.000781 | 0.004678 |
| GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.29% (3/70) | 4.07 | 0.000785 | 0.004692 |
| GO:0009987 | cellular process | 71.43% (50/70) | 0.45 | 0.000814 | 0.004831 |
| GO:0035770 | ribonucleoprotein granule | 7.14% (5/70) | 2.79 | 0.000812 | 0.004833 |
| GO:0014042 | positive regulation of neuron maturation | 2.86% (2/70) | 5.54 | 0.000851 | 0.005 |
| GO:0002274 | myeloid leukocyte activation | 2.86% (2/70) | 5.54 | 0.000851 | 0.005 |
| GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 2.86% (2/70) | 5.54 | 0.000851 | 0.005 |
| GO:0043167 | ion binding | 34.29% (24/70) | 0.92 | 0.000932 | 0.005408 |
| GO:0140220 | pathogen-containing vacuole | 2.86% (2/70) | 5.48 | 0.000923 | 0.005412 |
| GO:0045807 | positive regulation of endocytosis | 4.29% (3/70) | 3.98 | 0.00093 | 0.005414 |
| GO:0030666 | endocytic vesicle membrane | 4.29% (3/70) | 3.98 | 0.00093 | 0.005414 |
| GO:0030030 | cell projection organization | 7.14% (5/70) | 2.73 | 0.000954 | 0.005523 |
| GO:0051457 | maintenance of protein location in nucleus | 2.86% (2/70) | 5.42 | 0.000999 | 0.005764 |
| GO:0060627 | regulation of vesicle-mediated transport | 7.14% (5/70) | 2.72 | 0.001006 | 0.005785 |
| GO:0005778 | peroxisomal membrane | 4.29% (3/70) | 3.93 | 0.001035 | 0.005896 |
| GO:0031903 | microbody membrane | 4.29% (3/70) | 3.93 | 0.001035 | 0.005896 |
| GO:0005938 | cell cortex | 5.71% (4/70) | 3.18 | 0.001029 | 0.005899 |
| GO:0030234 | enzyme regulator activity | 10.0% (7/70) | 2.14 | 0.001063 | 0.006019 |
| GO:1901564 | organonitrogen compound metabolic process | 38.57% (27/70) | 0.82 | 0.001063 | 0.006036 |
| GO:0014041 | regulation of neuron maturation | 2.86% (2/70) | 5.37 | 0.001078 | 0.006067 |
| GO:0060999 | positive regulation of dendritic spine development | 2.86% (2/70) | 5.37 | 0.001078 | 0.006067 |
| GO:0009920 | cell plate formation involved in plant-type cell wall biogenesis | 2.86% (2/70) | 5.32 | 0.00116 | 0.006486 |
| GO:0043223 | cytoplasmic SCF ubiquitin ligase complex | 2.86% (2/70) | 5.32 | 0.00116 | 0.006486 |
| GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 4.29% (3/70) | 3.86 | 0.001176 | 0.006561 |
| GO:0009755 | hormone-mediated signaling pathway | 14.29% (10/70) | 1.66 | 0.001191 | 0.00662 |
| GO:0016197 | endosomal transport | 5.71% (4/70) | 3.11 | 0.001225 | 0.006793 |
| GO:0048592 | eye morphogenesis | 2.86% (2/70) | 5.27 | 0.001244 | 0.006794 |
| GO:0017156 | calcium-ion regulated exocytosis | 2.86% (2/70) | 5.27 | 0.001244 | 0.006794 |
| GO:0047496 | vesicle transport along microtubule | 2.86% (2/70) | 5.27 | 0.001244 | 0.006794 |
| GO:0070382 | exocytic vesicle | 4.29% (3/70) | 3.84 | 0.001236 | 0.006812 |
| GO:0017157 | regulation of exocytosis | 4.29% (3/70) | 3.84 | 0.001236 | 0.006812 |
| GO:0140352 | export from cell | 7.14% (5/70) | 2.64 | 0.001283 | 0.006984 |
| GO:0002366 | leukocyte activation involved in immune response | 2.86% (2/70) | 5.22 | 0.001331 | 0.007123 |
| GO:0050775 | positive regulation of dendrite morphogenesis | 2.86% (2/70) | 5.22 | 0.001331 | 0.007123 |
| GO:1990444 | F-box domain binding | 2.86% (2/70) | 5.22 | 0.001331 | 0.007123 |
| GO:0050805 | negative regulation of synaptic transmission | 2.86% (2/70) | 5.22 | 0.001331 | 0.007123 |
| GO:1902305 | regulation of sodium ion transmembrane transport | 2.86% (2/70) | 5.22 | 0.001331 | 0.007123 |
| GO:0031984 | organelle subcompartment | 11.43% (8/70) | 1.9 | 0.001329 | 0.007215 |
| GO:0002920 | regulation of humoral immune response | 2.86% (2/70) | 5.17 | 0.001421 | 0.007519 |
| GO:1903431 | positive regulation of cell maturation | 2.86% (2/70) | 5.17 | 0.001421 | 0.007519 |
| GO:0002263 | cell activation involved in immune response | 2.86% (2/70) | 5.17 | 0.001421 | 0.007519 |
| GO:0098586 | cellular response to virus | 2.86% (2/70) | 5.17 | 0.001421 | 0.007519 |
| GO:0005815 | microtubule organizing center | 7.14% (5/70) | 2.59 | 0.001482 | 0.007815 |
| GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.86% (2/70) | 5.13 | 0.001514 | 0.007965 |
| GO:1903532 | positive regulation of secretion by cell | 4.29% (3/70) | 3.71 | 0.0016 | 0.008389 |
| GO:0005802 | trans-Golgi network | 8.57% (6/70) | 2.26 | 0.001614 | 0.008394 |
| GO:0010765 | positive regulation of sodium ion transport | 2.86% (2/70) | 5.08 | 0.00161 | 0.008397 |
| GO:0106027 | neuron projection organization | 2.86% (2/70) | 5.08 | 0.00161 | 0.008397 |
| GO:0051047 | positive regulation of secretion | 4.29% (3/70) | 3.69 | 0.001672 | 0.008671 |
| GO:0030659 | cytoplasmic vesicle membrane | 8.57% (6/70) | 2.24 | 0.001697 | 0.008776 |
| GO:0003723 | RNA binding | 17.14% (12/70) | 1.4 | 0.001729 | 0.008916 |
| GO:0019428 | allantoin biosynthetic process | 1.43% (1/70) | 9.13 | 0.001791 | 0.009107 |
| GO:0033971 | hydroxyisourate hydrolase activity | 1.43% (1/70) | 9.13 | 0.001791 | 0.009107 |
| GO:0051997 | 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity | 1.43% (1/70) | 9.13 | 0.001791 | 0.009107 |
| GO:1904106 | protein localization to microvillus | 1.43% (1/70) | 9.13 | 0.001791 | 0.009107 |
| GO:1904970 | brush border assembly | 1.43% (1/70) | 9.13 | 0.001791 | 0.009107 |
| GO:0032879 | regulation of localization | 14.29% (10/70) | 1.58 | 0.001798 | 0.009118 |
| GO:0031143 | pseudopodium | 2.86% (2/70) | 5.0 | 0.00181 | 0.009131 |
| GO:0033522 | histone H2A ubiquitination | 2.86% (2/70) | 5.0 | 0.00181 | 0.009131 |
| GO:0034605 | cellular response to heat | 5.71% (4/70) | 2.95 | 0.001829 | 0.009202 |
| GO:1903429 | regulation of cell maturation | 2.86% (2/70) | 4.96 | 0.001915 | 0.009579 |
| GO:0010390 | histone monoubiquitination | 2.86% (2/70) | 4.96 | 0.001915 | 0.009579 |
| GO:0007034 | vacuolar transport | 5.71% (4/70) | 2.92 | 0.001995 | 0.009956 |
| GO:0051962 | positive regulation of nervous system development | 4.29% (3/70) | 3.59 | 0.002024 | 0.010043 |
| GO:0007112 | male meiosis cytokinesis | 2.86% (2/70) | 4.92 | 0.002022 | 0.01006 |
| GO:0012506 | vesicle membrane | 8.57% (6/70) | 2.18 | 0.002132 | 0.010469 |
| GO:0030027 | lamellipodium | 2.86% (2/70) | 4.88 | 0.002132 | 0.010494 |
| GO:0098563 | intrinsic component of synaptic vesicle membrane | 2.86% (2/70) | 4.88 | 0.002132 | 0.010494 |
| GO:1903533 | regulation of protein targeting | 2.86% (2/70) | 4.88 | 0.002132 | 0.010494 |
| GO:0050790 | regulation of catalytic activity | 11.43% (8/70) | 1.79 | 0.002154 | 0.010549 |
| GO:0005813 | centrosome | 5.71% (4/70) | 2.85 | 0.002331 | 0.011383 |
| GO:0043248 | proteasome assembly | 2.86% (2/70) | 4.8 | 0.00236 | 0.011433 |
| GO:0030017 | sarcomere | 2.86% (2/70) | 4.8 | 0.00236 | 0.011433 |
| GO:1903305 | regulation of regulated secretory pathway | 2.86% (2/70) | 4.8 | 0.00236 | 0.011433 |
| GO:0099080 | supramolecular complex | 10.0% (7/70) | 1.93 | 0.002411 | 0.011652 |
| GO:0090596 | sensory organ morphogenesis | 2.86% (2/70) | 4.77 | 0.002478 | 0.011819 |
| GO:0099738 | cell cortex region | 2.86% (2/70) | 4.77 | 0.002478 | 0.011819 |
| GO:0002090 | regulation of receptor internalization | 2.86% (2/70) | 4.77 | 0.002478 | 0.011819 |
| GO:0120035 | regulation of plasma membrane bounded cell projection organization | 5.71% (4/70) | 2.83 | 0.00247 | 0.011873 |
| GO:0098796 | membrane protein complex | 8.57% (6/70) | 2.13 | 0.002466 | 0.011887 |
| GO:0098793 | presynapse | 4.29% (3/70) | 3.48 | 0.002512 | 0.011951 |
| GO:0031461 | cullin-RING ubiquitin ligase complex | 5.71% (4/70) | 2.82 | 0.002527 | 0.01196 |
| GO:0005759 | mitochondrial matrix | 5.71% (4/70) | 2.82 | 0.002527 | 0.01196 |
| GO:0009408 | response to heat | 10.0% (7/70) | 1.91 | 0.002559 | 0.01208 |
| GO:0072595 | maintenance of protein localization in organelle | 2.86% (2/70) | 4.73 | 0.002599 | 0.012207 |
| GO:0060998 | regulation of dendritic spine development | 2.86% (2/70) | 4.73 | 0.002599 | 0.012207 |
| GO:0000956 | nuclear-transcribed mRNA catabolic process | 4.29% (3/70) | 3.45 | 0.002657 | 0.012416 |
| GO:0045335 | phagocytic vesicle | 4.29% (3/70) | 3.45 | 0.002657 | 0.012416 |
| GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 2.86% (2/70) | 4.7 | 0.002722 | 0.012691 |
| GO:0099518 | vesicle cytoskeletal trafficking | 2.86% (2/70) | 4.67 | 0.002849 | 0.013246 |
| GO:0007030 | Golgi organization | 4.29% (3/70) | 3.41 | 0.002909 | 0.013458 |
| GO:0051640 | organelle localization | 7.14% (5/70) | 2.36 | 0.002905 | 0.013472 |
| GO:0005730 | nucleolus | 11.43% (8/70) | 1.72 | 0.002939 | 0.013562 |
| GO:0071840 | cellular component organization or biogenesis | 31.43% (22/70) | 0.85 | 0.002963 | 0.013638 |
| GO:0010883 | regulation of lipid storage | 2.86% (2/70) | 4.63 | 0.002978 | 0.01364 |
| GO:0090317 | negative regulation of intracellular protein transport | 2.86% (2/70) | 4.63 | 0.002978 | 0.01364 |
| GO:0005768 | endosome | 11.43% (8/70) | 1.71 | 0.003019 | 0.013793 |
| GO:0098772 | molecular function regulator activity | 10.0% (7/70) | 1.86 | 0.003106 | 0.014157 |
| GO:0016043 | cellular component organization | 30.0% (21/70) | 0.88 | 0.003134 | 0.014251 |
| GO:0065009 | regulation of molecular function | 14.29% (10/70) | 1.46 | 0.003177 | 0.014376 |
| GO:0046916 | cellular transition metal ion homeostasis | 4.29% (3/70) | 3.36 | 0.003176 | 0.014403 |
| GO:0050789 | regulation of biological process | 50.0% (35/70) | 0.58 | 0.003234 | 0.014595 |
| GO:0019905 | syntaxin binding | 2.86% (2/70) | 4.57 | 0.003244 | 0.014606 |
| GO:0051094 | positive regulation of developmental process | 11.43% (8/70) | 1.68 | 0.003355 | 0.015034 |
| GO:0005795 | Golgi stack | 2.86% (2/70) | 4.54 | 0.003381 | 0.01504 |
| GO:0048814 | regulation of dendrite morphogenesis | 2.86% (2/70) | 4.54 | 0.003381 | 0.01504 |
| GO:0002028 | regulation of sodium ion transport | 2.86% (2/70) | 4.54 | 0.003381 | 0.01504 |
| GO:0005773 | vacuole | 12.86% (9/70) | 1.56 | 0.003352 | 0.015055 |
| GO:0034764 | positive regulation of transmembrane transport | 4.29% (3/70) | 3.31 | 0.003515 | 0.015596 |
| GO:0050793 | regulation of developmental process | 22.86% (16/70) | 1.05 | 0.00354 | 0.015672 |
| GO:0001560 | regulation of cell growth by extracellular stimulus | 1.43% (1/70) | 8.13 | 0.003579 | 0.015691 |
| GO:0016920 | pyroglutamyl-peptidase activity | 1.43% (1/70) | 8.13 | 0.003579 | 0.015691 |
| GO:0033081 | regulation of T cell differentiation in thymus | 1.43% (1/70) | 8.13 | 0.003579 | 0.015691 |
| GO:0050957 | equilibrioception | 1.43% (1/70) | 8.13 | 0.003579 | 0.015691 |
| GO:0007349 | cellularization | 2.86% (2/70) | 4.48 | 0.003663 | 0.01595 |
| GO:0045921 | positive regulation of exocytosis | 2.86% (2/70) | 4.48 | 0.003663 | 0.01595 |
| GO:1903725 | regulation of phospholipid metabolic process | 2.86% (2/70) | 4.48 | 0.003663 | 0.01595 |
| GO:0007265 | Ras protein signal transduction | 2.86% (2/70) | 4.45 | 0.003809 | 0.016465 |
| GO:0006301 | postreplication repair | 2.86% (2/70) | 4.45 | 0.003809 | 0.016465 |
| GO:0098791 | Golgi apparatus subcompartment | 8.57% (6/70) | 2.01 | 0.003795 | 0.016482 |
| GO:0014069 | postsynaptic density | 4.29% (3/70) | 3.25 | 0.003937 | 0.016943 |
| GO:0099572 | postsynaptic specialization | 4.29% (3/70) | 3.25 | 0.003937 | 0.016943 |
| GO:0032387 | negative regulation of intracellular transport | 2.86% (2/70) | 4.42 | 0.003956 | 0.016945 |
| GO:0036064 | ciliary basal body | 2.86% (2/70) | 4.42 | 0.003956 | 0.016945 |
| GO:0000139 | Golgi membrane | 7.14% (5/70) | 2.25 | 0.004104 | 0.017538 |
| GO:0065007 | biological regulation | 52.86% (37/70) | 0.53 | 0.004174 | 0.017794 |
| GO:0050804 | modulation of chemical synaptic transmission | 4.29% (3/70) | 3.17 | 0.004593 | 0.019446 |
| GO:0099177 | regulation of trans-synaptic signaling | 4.29% (3/70) | 3.17 | 0.004593 | 0.019446 |
| GO:0071987 | WD40-repeat domain binding | 2.86% (2/70) | 4.32 | 0.004574 | 0.019454 |
| GO:0050767 | regulation of neurogenesis | 4.29% (3/70) | 3.16 | 0.004662 | 0.019693 |
| GO:0140096 | catalytic activity, acting on a protein | 21.43% (15/70) | 1.05 | 0.004692 | 0.019777 |
| GO:0006402 | mRNA catabolic process | 4.29% (3/70) | 3.16 | 0.004732 | 0.019896 |
| GO:0033206 | meiotic cytokinesis | 2.86% (2/70) | 4.27 | 0.004898 | 0.020364 |
| GO:0051787 | misfolded protein binding | 2.86% (2/70) | 4.27 | 0.004898 | 0.020364 |
| GO:0097602 | cullin family protein binding | 2.86% (2/70) | 4.27 | 0.004898 | 0.020364 |
| GO:0071704 | organic substance metabolic process | 52.86% (37/70) | 0.51 | 0.004922 | 0.020416 |
| GO:0032559 | adenyl ribonucleotide binding | 14.29% (10/70) | 1.37 | 0.004894 | 0.020485 |
| GO:0008152 | metabolic process | 55.71% (39/70) | 0.49 | 0.004892 | 0.020523 |
| GO:0030554 | adenyl nucleotide binding | 14.29% (10/70) | 1.37 | 0.00507 | 0.020892 |
| GO:0048646 | anatomical structure formation involved in morphogenesis | 11.43% (8/70) | 1.58 | 0.005086 | 0.020909 |
| GO:0045879 | negative regulation of smoothened signaling pathway | 2.86% (2/70) | 4.24 | 0.005064 | 0.020913 |
| GO:0016574 | histone ubiquitination | 2.86% (2/70) | 4.24 | 0.005064 | 0.020913 |
| GO:0045055 | regulated exocytosis | 2.86% (2/70) | 4.22 | 0.005233 | 0.021418 |
| GO:0050714 | positive regulation of protein secretion | 2.86% (2/70) | 4.22 | 0.005233 | 0.021418 |
| GO:0031974 | membrane-enclosed lumen | 8.57% (6/70) | 1.9 | 0.005391 | 0.021634 |
| GO:0043233 | organelle lumen | 8.57% (6/70) | 1.9 | 0.005391 | 0.021634 |
| GO:0070013 | intracellular organelle lumen | 8.57% (6/70) | 1.9 | 0.005391 | 0.021634 |
| GO:0033554 | cellular response to stress | 20.0% (14/70) | 1.08 | 0.005405 | 0.021645 |
| GO:0019628 | urate catabolic process | 1.43% (1/70) | 7.54 | 0.005363 | 0.021663 |
| GO:0005113 | patched binding | 1.43% (1/70) | 7.54 | 0.005363 | 0.021663 |
| GO:0016189 | synaptic vesicle to endosome fusion | 1.43% (1/70) | 7.54 | 0.005363 | 0.021663 |
| GO:0005818 | aster | 1.43% (1/70) | 7.54 | 0.005363 | 0.021663 |
| GO:0070830 | bicellular tight junction assembly | 1.43% (1/70) | 7.54 | 0.005363 | 0.021663 |
| GO:1905618 | obsolete positive regulation of miRNA-mediated gene silencing by inhibition of translation | 1.43% (1/70) | 7.54 | 0.005363 | 0.021663 |
| GO:0051656 | establishment of organelle localization | 5.71% (4/70) | 2.49 | 0.005673 | 0.022666 |
| GO:0050773 | regulation of dendrite development | 2.86% (2/70) | 4.15 | 0.005754 | 0.022891 |
| GO:0072384 | organelle transport along microtubule | 2.86% (2/70) | 4.15 | 0.005754 | 0.022891 |
| GO:1902903 | regulation of supramolecular fiber organization | 4.29% (3/70) | 3.05 | 0.005772 | 0.022915 |
| GO:0098978 | glutamatergic synapse | 4.29% (3/70) | 3.04 | 0.005851 | 0.02318 |
| GO:0032154 | cleavage furrow | 2.86% (2/70) | 4.13 | 0.005932 | 0.02335 |
| GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 2.86% (2/70) | 4.13 | 0.005932 | 0.02335 |
| GO:0045595 | regulation of cell differentiation | 8.57% (6/70) | 1.87 | 0.005957 | 0.023397 |
| GO:1903046 | meiotic cell cycle process | 7.14% (5/70) | 2.12 | 0.005923 | 0.023414 |
| GO:0008333 | endosome to lysosome transport | 2.86% (2/70) | 4.1 | 0.006114 | 0.023962 |
| GO:0061630 | ubiquitin protein ligase activity | 5.71% (4/70) | 2.46 | 0.006133 | 0.023986 |
| GO:0030139 | endocytic vesicle | 4.29% (3/70) | 3.0 | 0.006424 | 0.025017 |
| GO:0005770 | late endosome | 4.29% (3/70) | 3.0 | 0.006424 | 0.025017 |
| GO:0034655 | nucleobase-containing compound catabolic process | 5.71% (4/70) | 2.44 | 0.006508 | 0.025291 |
| GO:0061659 | ubiquitin-like protein ligase activity | 5.71% (4/70) | 2.43 | 0.006562 | 0.02545 |
| GO:0045597 | positive regulation of cell differentiation | 5.71% (4/70) | 2.42 | 0.006785 | 0.026256 |
| GO:0030133 | transport vesicle | 4.29% (3/70) | 2.96 | 0.00694 | 0.026802 |
| GO:0000740 | nuclear membrane fusion | 1.43% (1/70) | 7.13 | 0.007144 | 0.027419 |
| GO:0010620 | negative regulation of transcription by transcription factor catabolism | 1.43% (1/70) | 7.13 | 0.007144 | 0.027419 |
| GO:0061654 | NEDD8 conjugating enzyme activity | 1.43% (1/70) | 7.13 | 0.007144 | 0.027419 |
| GO:1901363 | heterocyclic compound binding | 38.57% (27/70) | 0.64 | 0.007216 | 0.027635 |
| GO:0031901 | early endosome membrane | 2.86% (2/70) | 3.98 | 0.007254 | 0.027724 |
| GO:0051224 | negative regulation of protein transport | 2.86% (2/70) | 3.94 | 0.007654 | 0.029071 |
| GO:0030658 | transport vesicle membrane | 2.86% (2/70) | 3.94 | 0.007654 | 0.029071 |
| GO:0032507 | maintenance of protein location in cell | 2.86% (2/70) | 3.94 | 0.007654 | 0.029071 |
| GO:0098588 | bounding membrane of organelle | 17.14% (12/70) | 1.13 | 0.007761 | 0.02942 |
| GO:0090087 | regulation of peptide transport | 2.86% (2/70) | 3.92 | 0.007857 | 0.029722 |
| GO:0097159 | organic cyclic compound binding | 38.57% (27/70) | 0.63 | 0.007946 | 0.029997 |
| GO:0000919 | cell plate assembly | 2.86% (2/70) | 3.9 | 0.008063 | 0.030377 |
| GO:0016071 | mRNA metabolic process | 8.57% (6/70) | 1.77 | 0.008186 | 0.030776 |
| GO:0030662 | coated vesicle membrane | 2.86% (2/70) | 3.88 | 0.008272 | 0.030973 |
| GO:0032869 | cellular response to insulin stimulus | 2.86% (2/70) | 3.88 | 0.008272 | 0.030973 |
| GO:0006149 | deoxyinosine catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0006154 | adenosine catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0006157 | deoxyadenosine catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0006161 | deoxyguanosine catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0006204 | IMP catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0042453 | deoxyguanosine metabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0046038 | GMP catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0046053 | dAMP metabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0046055 | dGMP catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0046059 | dAMP catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0046090 | deoxyadenosine metabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0046094 | deoxyinosine metabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0032120 | ascospore-type prospore membrane formation | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0001967 | suckling behavior | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0031372 | UBC13-MMS2 complex | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0035370 | UBC13-UEV1A complex | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0036369 | transcription factor catabolic process | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0015870 | acetylcholine transport | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0051523 | cell growth mode switching, monopolar to bipolar | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0061171 | establishment of bipolar cell polarity | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0061389 | regulation of direction of cell growth | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0120192 | tight junction assembly | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0120193 | tight junction organization | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:1901374 | acetate ester transport | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0051600 | regulation of endocytosis by exocyst localization | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0140025 | contractile vacuole tethering involved in discharge | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0001675 | acrosome assembly | 1.43% (1/70) | 6.8 | 0.008923 | 0.031078 |
| GO:0010975 | regulation of neuron projection development | 4.29% (3/70) | 2.82 | 0.00904 | 0.031429 |
| GO:0018205 | peptidyl-lysine modification | 5.71% (4/70) | 2.3 | 0.009079 | 0.031502 |
| GO:1903530 | regulation of secretion by cell | 4.29% (3/70) | 2.85 | 0.008435 | 0.03152 |
| GO:0033643 | host cell part | 2.86% (2/70) | 3.8 | 0.009129 | 0.031559 |
| GO:0008589 | regulation of smoothened signaling pathway | 2.86% (2/70) | 3.8 | 0.009129 | 0.031559 |
| GO:0005524 | ATP binding | 12.86% (9/70) | 1.33 | 0.00917 | 0.031642 |
| GO:0019439 | aromatic compound catabolic process | 7.14% (5/70) | 1.99 | 0.008493 | 0.031673 |
| GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.86% (2/70) | 3.79 | 0.00935 | 0.032201 |
| GO:0002700 | regulation of production of molecular mediator of immune response | 2.86% (2/70) | 3.84 | 0.008696 | 0.032363 |
| GO:0072594 | establishment of protein localization to organelle | 5.71% (4/70) | 2.31 | 0.008743 | 0.032473 |
| GO:0006401 | RNA catabolic process | 4.29% (3/70) | 2.83 | 0.008836 | 0.032753 |
| GO:1904950 | negative regulation of establishment of protein localization | 2.86% (2/70) | 3.82 | 0.008911 | 0.032835 |
| GO:0008021 | synaptic vesicle | 2.86% (2/70) | 3.82 | 0.008911 | 0.032835 |
| GO:0045185 | maintenance of protein location | 2.86% (2/70) | 3.82 | 0.008911 | 0.032835 |
| GO:0071375 | cellular response to peptide hormone stimulus | 2.86% (2/70) | 3.75 | 0.009798 | 0.03368 |
| GO:0055076 | transition metal ion homeostasis | 4.29% (3/70) | 2.76 | 0.009996 | 0.034297 |
| GO:0050794 | regulation of cellular process | 42.86% (30/70) | 0.55 | 0.010158 | 0.03479 |
| GO:0032588 | trans-Golgi network membrane | 2.86% (2/70) | 3.68 | 0.010721 | 0.034844 |
| GO:0006900 | vesicle budding from membrane | 2.86% (2/70) | 3.68 | 0.010721 | 0.034844 |
| GO:0006147 | guanine catabolic process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0009114 | hypoxanthine catabolic process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0009115 | xanthine catabolic process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0046054 | dGMP metabolic process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0046100 | hypoxanthine metabolic process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0046110 | xanthine metabolic process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0090088 | regulation of oligopeptide transport | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0090089 | regulation of dipeptide transport | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:1990303 | UBR1-RAD6 ubiquitin ligase complex | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:1990304 | MUB1-RAD6-UBR2 ubiquitin ligase complex | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:2000639 | negative regulation of SREBP signaling pathway | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0034333 | adherens junction assembly | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0045196 | establishment or maintenance of neuroblast polarity | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0051516 | regulation of bipolar cell growth | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0051518 | positive regulation of bipolar cell growth | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0051519 | activation of bipolar cell growth | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0048210 | Golgi vesicle fusion to target membrane | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0051459 | regulation of corticotropin secretion | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0051461 | positive regulation of corticotropin secretion | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0051601 | exocyst localization | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0000346 | transcription export complex | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0050886 | endocrine process | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0010954 | positive regulation of protein processing | 1.43% (1/70) | 6.54 | 0.010698 | 0.03489 |
| GO:0005507 | copper ion binding | 4.29% (3/70) | 2.72 | 0.010778 | 0.034965 |
| GO:0007005 | mitochondrion organization | 4.29% (3/70) | 2.72 | 0.010892 | 0.035275 |
| GO:0009873 | ethylene-activated signaling pathway | 4.29% (3/70) | 2.74 | 0.010438 | 0.035683 |
| GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 2.86% (2/70) | 3.7 | 0.010487 | 0.035783 |
| GO:0005764 | lysosome | 4.29% (3/70) | 2.73 | 0.010551 | 0.035868 |
| GO:0051046 | regulation of secretion | 4.29% (3/70) | 2.73 | 0.010551 | 0.035868 |
| GO:0099568 | cytoplasmic region | 2.86% (2/70) | 3.65 | 0.011197 | 0.036199 |
| GO:0005886 | plasma membrane | 24.29% (17/70) | 0.83 | 0.011781 | 0.03802 |
| GO:1901361 | organic cyclic compound catabolic process | 7.14% (5/70) | 1.87 | 0.011999 | 0.038657 |
| GO:0006196 | AMP catabolic process | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0009172 | purine deoxyribonucleoside monophosphate catabolic process | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0031097 | medial cortex | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0005047 | signal recognition particle binding | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0043657 | host cell | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0044395 | protein targeting to vacuolar membrane | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:1903778 | protein localization to vacuolar membrane | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0035456 | response to interferon-beta | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0035458 | cellular response to interferon-beta | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0033128 | obsolete negative regulation of histone phosphorylation | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0097505 | Rad6-Rad18 complex | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0090522 | vesicle tethering involved in exocytosis | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0046784 | viral mRNA export from host cell nucleus | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:1903319 | positive regulation of protein maturation | 1.43% (1/70) | 6.32 | 0.01247 | 0.039215 |
| GO:0048518 | positive regulation of biological process | 28.57% (20/70) | 0.73 | 0.01301 | 0.040843 |
| GO:0033365 | protein localization to organelle | 7.14% (5/70) | 1.83 | 0.013359 | 0.041868 |
| GO:1904064 | positive regulation of cation transmembrane transport | 2.86% (2/70) | 3.51 | 0.013451 | 0.042085 |
| GO:0006897 | endocytosis | 4.29% (3/70) | 2.6 | 0.013592 | 0.042454 |
| GO:0051650 | establishment of vesicle localization | 2.86% (2/70) | 3.5 | 0.013712 | 0.042759 |
| GO:0010769 | regulation of cell morphogenesis involved in differentiation | 4.29% (3/70) | 2.59 | 0.013854 | 0.043128 |
| GO:0060271 | cilium assembly | 2.86% (2/70) | 3.47 | 0.014242 | 0.043385 |
| GO:0051648 | vesicle localization | 2.86% (2/70) | 3.48 | 0.013976 | 0.043435 |
| GO:0009170 | purine deoxyribonucleoside monophosphate metabolic process | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0046098 | guanine metabolic process | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0090161 | Golgi ribbon formation | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0120174 | stress-induced homeostatically regulated protein degradation pathway | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:2000638 | regulation of SREBP signaling pathway | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0030911 | TPR domain binding | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0099022 | vesicle tethering | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0050498 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with 2-oxoglutarate as one donor, and the other dehydrogenated | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0044417 | translocation of molecules into host | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0062153 | C5-methylcytidine-containing RNA binding | 1.43% (1/70) | 6.13 | 0.014238 | 0.043445 |
| GO:0006612 | protein targeting to membrane | 2.86% (2/70) | 3.45 | 0.01451 | 0.044129 |
| GO:1990904 | ribonucleoprotein complex | 8.57% (6/70) | 1.59 | 0.014884 | 0.045191 |
| GO:0045664 | regulation of neuron differentiation | 2.86% (2/70) | 3.42 | 0.015053 | 0.045555 |
| GO:0099023 | vesicle tethering complex | 2.86% (2/70) | 3.42 | 0.015053 | 0.045555 |
| GO:0000469 | cleavage involved in rRNA processing | 2.86% (2/70) | 3.41 | 0.015328 | 0.046311 |
| GO:0000281 | mitotic cytokinesis | 2.86% (2/70) | 3.4 | 0.015605 | 0.046993 |
| GO:0007041 | lysosomal transport | 2.86% (2/70) | 3.4 | 0.015605 | 0.046993 |
| GO:0010286 | heat acclimation | 4.29% (3/70) | 2.52 | 0.015774 | 0.047423 |
| GO:0005483 | soluble NSF attachment protein activity | 1.43% (1/70) | 5.96 | 0.016004 | 0.047651 |
| GO:0075733 | intracellular transport of virus | 1.43% (1/70) | 5.96 | 0.016004 | 0.047651 |
| GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.43% (1/70) | 5.96 | 0.016004 | 0.047651 |
| GO:0045046 | protein import into peroxisome membrane | 1.43% (1/70) | 5.96 | 0.016004 | 0.047651 |
| GO:0045486 | naringenin 3-dioxygenase activity | 1.43% (1/70) | 5.96 | 0.016004 | 0.047651 |
| GO:0071000 | response to magnetism | 1.43% (1/70) | 5.96 | 0.016004 | 0.047651 |
| GO:0044270 | cellular nitrogen compound catabolic process | 5.71% (4/70) | 2.05 | 0.016226 | 0.048233 |
| GO:0000911 | cytokinesis by cell plate formation | 2.86% (2/70) | 3.36 | 0.016449 | 0.048738 |
| GO:0046700 | heterocycle catabolic process | 5.71% (4/70) | 2.04 | 0.016424 | 0.048744 |
| GO:0032868 | response to insulin | 2.86% (2/70) | 3.34 | 0.016734 | 0.049347 |
| GO:0044782 | cilium organization | 2.86% (2/70) | 3.34 | 0.016734 | 0.049347 |
| GO:0051651 | maintenance of location in cell | 2.86% (2/70) | 3.34 | 0.016734 | 0.049347 |